| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $22,811,655 ) (Continued on the next page) |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | UM1AI068616 | SDMC - IMPAACT Leadership Group | 000 | 20 | NIH | 12/20/2025 | $3,500,000 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01AG044346 | Mechanisms Specific to the Beneficial Effects of Dietary Restriction | 001 | 11 | NIH | 1/16/2026 | $479,583 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | K99CA297010 | Human leukocyte antigen and immune response in non-small cell lung cancer: A multi-omics approach | 000 | 2 | NIH | 1/28/2026 | $108,743 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | F32AI174653 | Dissecting virulence gene regulatory pathways in M. tuberculosis clinical isolates | 000 | 3 | NIH | 1/8/2026 | $85,360 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | F32AI174653 | Dissecting virulence gene regulatory pathways in M. tuberculosis clinical isolates | 001 | 3 | NIH | 4/2/2026 | $1,464 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | F31ES036462 | Investigating the Role of Apoptosis in Early Life Vulnerability to Lead-Induced Neurotoxicity | 000 | 2 | NIH | 3/5/2026 | $42,220 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | F31CA281083 | Understanding and exploiting apoptotic dysregulation in ovarian cancer | 000 | 3 | NIH | 2/23/2026 | $45,284 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | F31AI197660 | Utilizing biochemical and functional genomic approaches to uncover key host invasion receptors in Plasmodium vivax | 001 | 1 | NIH | 4/2/2026 | $576 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | F31AI197660 | Utilizing biochemical and functional genomic approaches to uncover key host invasion receptors in Plasmodium vivax | 000 | 1 | NIH | 3/27/2026 | $49,145 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R21AI197144 | Determining the role of micronutrient deficiency in the immune response to oral rotavirus vaccine in a low-resource setting. | 000 | 1 | NIH | 3/27/2026 | $228,000 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R21AI187884 | Identifying the drivers of ESX1 evolution in Mycobacterium tuberculosis | 000 | 2 | NIH | 11/25/2025 | $232,050 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01NS126260 | Biomarkers and Risk Factors for Prodromal Parkinson's Disease and its Progression | 000 | 5 | NIH | 3/23/2026 | $643,218 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01MD018750 | A culturally-tailored dietary trial for cardiometabolic health in Puerto Rico | 001 | 4 | NIH | 2/11/2026 | $56,128 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01MD018750 | A culturally-tailored dietary trial for cardiometabolic health in Puerto Rico | 000 | 4 | NIH | 1/27/2026 | $505,164 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01HL177625 | MicroRNAs in Airway Smooth Muscle Function and Asthma | 001 | 2 | NIH | 3/25/2026 | $17,810 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01HL177625 | MicroRNAs in Airway Smooth Muscle Function and Asthma | 000 | 2 | NIH | 2/9/2026 | $563,958 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01GM148494 | Federated and transfer learning methods for cross-ancestry and cross-phenotype integration of genomic datasets | 001 | 4 | NIH | 3/18/2026 | $41,973 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01GM148494 | Federated and transfer learning methods for cross-ancestry and cross-phenotype integration of genomic datasets | 000 | 4 | NIH | 1/14/2026 | $377,754 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01ES033185 | Pregnancy and postpartum as vulnerable exposure windows: phthalates and maternal cardiometabolic health | 000 | 5 | NIH | 2/11/2026 | $592,031 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01ES035390 | A nationwide population-based study investigating the cardiovascular effects of exposure to particulate matter α-, β-, and γ-activities and individual radionuclides | 000 | 3 | NIH | 1/19/2026 | $644,817 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01ES035106 | Climate factors, racial/ethnic disparities, and menstrual cycle health | 000 | 4 | NIH | 1/30/2026 | $546,929 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01AI179949 | From bench to bednet: Developing novel mitochondrial inhibitors for killing Plasmodium in the malaria mosquito | 000 | 3 | NIH | 11/26/2025 | $681,106 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01AI177514 | Elucidating the biological mechanisms underlying the association between EBV and MS in African Americans | 000 | 2 | NIH | 12/3/2025 | $766,640 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01AI175348 | Trial of Zinc Supplements for Young Infants with Clinical Severe Infection in Tanzania | 001 | 4 | NIH | 2/25/2026 | $254,451 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01AI175348 | Trial of Zinc Supplements for Young Infants with Clinical Severe Infection in Tanzania | 001 | 4 | NIH | 2/25/2026 | $150,000 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01AI175348 | Trial of Zinc Supplements for Young Infants with Clinical Severe Infection in Tanzania | 000 | 4 | NIH | 2/20/2026 | $43,616 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01AI175348 | Trial of Zinc Supplements for Young Infants with Clinical Severe Infection in Tanzania | 000 | 4 | NIH | 2/20/2026 | $150,000 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | UM1AI068634 | Statistical and Data Management Center (SDMC), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG) | 000 | 20 | NIH | 12/20/2025 | $10,122,769 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | UM1AI068616 | SDMC - IMPAACT Leadership Group | 000 | 20 | NIH | 12/20/2025 | $3,998,221 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01AI168163 | Molecular basis of antimalarial drug resistance in Plasmodium vivax | 000 | 5 | NIH | 2/19/2026 | $702,840 |
| | 2026 | 2026 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R37CA248565 | Developmental regulation of apoptosis as a modifiable driver of radiotherapy-induced neurocognitive impairment in pediatric patients | 000 | 7 | NIH | 3/19/2026 | $354,502 |
| | 2026 | 2025 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R00CA248335 | Identifying optimal dynamic strategies for prostate cancer control | 000 | 6 | NIH | 3/12/2026 | $0 |
| | 2026 | 2025 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | K99CA297022 | Integrating a Multi-Omics Cohort Study with a Medically Tailored Meal Intervention to Target Ultra-Processed Foods for Colorectal Cancer Prevention and Control | 000 | 1 | NIH | 2/12/2026 | $0 |
| | 2026 | 2025 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | K99CA287059 | Learning about the effectiveness of lung cancer screening in real-world target populations | 000 | 2 | NIH | 2/12/2026 | $0 |
| | 2026 | 2025 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | K99AG086538 | Molecular profiles for mortality risk and longevity: a multiomics approach | 000 | 1 | NIH | 2/24/2026 | $0 |
| | 2026 | 2025 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | K99HD116975 | In Utero Exposure to Medications for Cardiometabolic Conditions and Risk of Congenital Malformations | 000 | 1 | NIH | 3/18/2026 | $0 |
| | 2026 | 2025 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | K00AG083306 | The Impact of SARS-CoV-2 Infection and Vaccination on the Risk of Alzheimer’s Disease and Related Dementias | 000 | 3 | NIH | 2/11/2026 | $0 |
| | 2026 | 2025 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | F32HD117535 | Prenatal exposure to maternal incarceration and infant and toddler health and development | 000 | 1 | NIH | 2/10/2026 | -$13,828 |
| | 2026 | 2025 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | F32HG012889 | Fine-mapping causal tissues at disease-associated loci to infer disease subtypes | 000 | 3 | NIH | 12/23/2025 | -$48,690 |
| | 2026 | 2025 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R21AI180508 | Bacteria-Virus interactions in genital herpes infections | 000 | 2 | NIH | 10/10/2025 | $0 |
| | 2026 | 2025 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R21AI180609 | Functional characterization of the Plasmodium falciparum invasion ligand bindome | 000 | 2 | NIH | 3/3/2026 | $0 |
| | 2026 | 2025 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01LM013616 | Methods for generalizing inferences from cluster randomized controlled trials to target populations | 000 | 4 | NIH | 10/23/2025 | $0 |
| | 2026 | 2025 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01MD017747 | Evaluating an Intervention to Improve Medication Access and Quality of Care for Patient Populations With Chronic Conditions | 000 | 4 | NIH | 3/12/2026 | $0 |
| | 2026 | 2025 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01HL143792 | Longitudinal Mechanisms of Food and Nutrition Security and Cardiometabolic Health in PROSPECT | 000 | 7 | NIH | 1/30/2026 | $0 |
| | 2026 | 2025 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01HL118264 | Mediterranean diet, Metabolites, and Cardiovascular Disease | 000 | 12 | NIH | 1/13/2026 | $0 |
| | 2026 | 2025 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01HD120132 | Tsepamo Next Generation: Optimizing HIV Treatment and Prevention Strategies for Pregnant Women in Botswana | 000 | 1 | NIH | 12/17/2025 | -$2,111 |
| | 2026 | 2025 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01HD101351 | Health Outcomes around Pregnancy and Exposure to HIV/ARV (HOPE): Extending the Reach of PHACS to Examine Women's Health | 002 | 5 | NIH | 2/27/2026 | $0 |
| | 2026 | 2025 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01HD101351 | Health Outcomes around Pregnancy and Exposure to HIV/ARV (HOPE): Extending the Reach of PHACS to Examine Women's Health | 001 | 5 | NIH | 1/14/2026 | $0 |
| | 2026 | 2025 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 1033 MASSACHUSETTS AVE STE 3 | CAMBRIDGE | MA | 02138-5366 | MIDDLESEX | USA | R01HD101351 | Health Outcomes around Pregnancy and Exposure to HIV/ARV (HOPE): Extending the Reach of PHACS to Examine Women's Health | 000 | 5 | NIH | 12/4/2025 | $0 |
|
